Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation in D3 Deficient ACO Patients
NCT03880734Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in asthma chronic obstructive pulmonary disease overlap syndrome (ACOS) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Forced Vital Capacity at 26 weeks, Forced Expiratory Volume in 1 Second at 26 weeks and 7 more. Started Mar 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
asthma chronic obstructive pulmonary disease overlap syndrome (ACOS)
Beyond the preview
Go deeper on NCT03880734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03880734.